WHO ICTRP trial
Effects of dexmedetomidine combined with lidocaine on postoperative immune…
ChiCTR2300070292 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300070292 |
|---|---|
| Public title | Effects of dexmedetomidine combined with lidocaine on postoperative immune function in patients with lung cancer |
| Scientific title | Effects of dexmedetomidine combined with lidocaine on postoperative immune function in patients with lung cancer |
| Primary sponsor | Tai'an Central Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Effects of dexmedetomidine combined with lidocaine on postoperative immune function in patients with lung cancer |
| Interventions | Dexmedetomidine hydrochloride galdocaine group:Dexmedetomidine hydrochloride galdocaine;Control group:Add 0.9% sodium chloride solution to the same amount of sugar water |
| Registration date | Apr 7, 2023 |
| Target size | Dexmedetomidine hydrochloride galdocaine group:30;Control group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: